Russell P. Bowler, MD, PhD, Victor Kim, MD, Elizabeth Regan, MD, André A. A. Williams, PhD, Stephanie A. Santorico, PhD, Barry J. Make, MD, FCCP, David A. Lynch, MD, John E. Hokanson, PhD, George R. Washko, MD, Peter Bercz, MD, Xavier Soler, MD, Nathaniel Marchetti, MD, FCCP, Gerard J. Criner, MD, FCCP, Joe Ramsdell, MD, FCCP, MeiLan K. Han, MD, Dawn Demeo, MD, Antonio Anzueto, MD, Alejandro Comellas, MD, James D. Crapo, MD, FCCP, Mark Dransfield, MD, J. Michael Wells, MD, Craig P. Hersh, MD, Neil MacIntyre, MD, FCCP, Fernando Martinez, MD, FCCP, Hrudaya P. Nath, MD, FCCP, Dennis Niewoehner, MD, FCCP, Frank Sciurba, MD, FCCP, Amir Sharafkhaneh, MD, FCCP, Edwin K. Silverman, MD, PhD, Edwin J. R. van Beek, MD, Carla Wilson, Christine Wendt, MD, Robert A. Wise, MD, FCCP and for the COPDGene investigators
Chest. 2014;146(4):941-950. doi:10.1378/chest.13-2946
The risk factors for acute episodes of respiratory disease in current and former smokers who do not have COPD are unknown.
Eight thousand two hundred forty-six non-Hispanic white and black current and former smokers in the Genetic Epidemiology of COPD (COPDGene) cohort had longitudinal follow-up (LFU) every 6 months to determine acute respiratory episodes requiring antibiotics or systemic corticosteroids, an ED visit, or hospitalization. Negative binomial regression was used to determine the factors associated with acute respiratory episodes. A Cox proportional hazards model was used to determine adjusted hazard ratios (HRs) for time to first episode and an acute episode of respiratory disease risk score.
At enrollment, 4,442 subjects did not have COPD, 658 had mild COPD, and 3,146 had moderate or worse COPD. Nine thousand three hundred three acute episodes of respiratory disease and 2,707 hospitalizations were reported in LFU (3,044 acute episodes of respiratory disease and 827 hospitalizations in those without COPD). Major predictors included acute episodes of respiratory disease in year prior to enrollment (HR, 1.20; 95% CI, 1.15-1.24 per exacerbation), airflow obstruction (HR, 0.94; 95% CI, 0.91-0.96 per 10% change in % predicted FEV1), and poor health-related quality of life (HR, 1.07; 95% CI, 1.06-1.08 for each 4-unit increase in St. George’s Respiratory Questionnaire score). Risks were similar for those with and without COPD.
Although acute episode of respiratory disease rates are higher in subjects with COPD, risk factors are similar, and at a population level, there are more episodes in smokers without COPD.